Clinical and pathological features of degenerative mitral valve disease: Billowing mitral leaflet versus fibroelastic deficiency

Annals of Thoracic and Cardiovascular Surgery

Volumn 20, Issue 6, 2014, Pages 987-994

  Matsumaru, Ichiro ^a   Eishi, Kiyoyuki ^a   Hashizume, Koji ^a   Kawano, Hiroaki ^b   Tsuneto, Akira ^b   Hayashi, Tomayoshi ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Mitral regurgitation; Mitral valve; Mitral valve repair; Pathology

Indexed keywords

GLYCOSAMINOGLYCAN;

ADULT; AGED; BIOPSY; CHEMISTRY; CHORDA TENDINEA; COMPARATIVE STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART VALVE REPLACEMENT; HUMAN; MALE; MIDDLE AGED; MITRAL ANNULOPLASTY; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE PROLAPSE; PATHOLOGY; PATHOPHYSIOLOGY; RECURRENT DISEASE; SEVERITY OF ILLNESS INDEX; SUTURING METHOD; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; BIOPSY; CHORDAE TENDINEAE; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; GLYCOSAMINOGLYCANS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE PROLAPSE; RECURRENCE; SEVERITY OF ILLNESS INDEX; SUTURE TECHNIQUES; TREATMENT OUTCOME;

EID: 84918834832     PISSN: 13411098     EISSN: 21861005     Source Type: Journal    
DOI: 10.5761/atcs.oa.13-00168     Document Type: Article

References (24)

1. Barlow JB, Pocock WA. Mitral valve billowing andprolapse: perspective at 25 years. Herz 1988; 13:227-34.
2. Carpentier A, Chauvaud S, Fabiani JN, et al. Reconstructivesurgery of mitral valve incompetence: tenyearappraisal. J Thorac Cardiovasc Surg 1980; 79:338-48.
3. Fornes P, Heudes D, Fuzellier JF, et al. Correlationbetween clinical and histologic patterns of degenerativemitral valve insufficiency: a histomorphometricstudy of 130 excised segments. Cardiovasc Pathol1999; 8: 81-92.
4. Matsukuma S, Eishi K, Yamachika S, et al. Risk factorsof posterior pericardial annuloplasty for isolatedposterior leaflet prolapse. Ann Thorac Surg 2005; 80:820-4.
5. McDonald PC, Wilson JE, McNeill S, et al. The challengeof defining normality for human mitral andaortic valves: geometrical and compositional analysis. Cardiovasc Pathol 2002; 11: 193-209.
6. Tamura K, Fukuda Y, Ishizaki M, et al. Abnormalitiesin elastic fibers and other connective-tissue componentsof floppy mitral valve. Am Heart J 1995; 129:1149-58.
7. Barber JE, Kasper FK, Ratliff NB, et al. Mechanicalproperties of myxomatous mitral valves. J ThoracCardiovasc Surg 2001; 122: 955-62.
8. Gupta V, Barzilla JE, Mendez JS, et al. Abundanceand location of proteoglycans and hyaluronan withinnormal and myxomatous mitral valves. CardiovascPathol 2009; 18: 191-7.
9. Grande-Allen KJ, Griffin BP, Ratliff NB, et al.Glycosaminoglycan profiles of myxomatous mitralleaflets and chordae parallel the severity of mechanicalalterations. J Am Coll Cardiol 2003; 42: 271-7.
10. Lis Y, Burleigh MC, Parker DJ, et al. Biochemical characterizationof individual normal, floppy and rheumatichuman mitral valves. Biochem J 1987; 244: 597-603.
11. Akhtar S, Meek KM, James V. Ultrastructure abnormalitiesin proteoglycans, collagen fibrils, and elasticfibers in normal and myxomatous mitral valve chordaetendineae. Cardiovasc Pathol 1999; 8: 191-201.
12. Baker PB, Bansal G, Boudoulas H, et al. Floppy mitralvalve chordae tendineae: histopathologic alterations. Hum Pathol 1988; 19: 507-12.
13. Scott-Jupp W, Barnett NL, Gallagher PJ, et al. Ultrastructuralchanges in spontaneous rupture of mitralchordae tendineae. J Pathol 1981; 133: 185-201.
14. Nesta F, Leyne M, Yosefy C, et al. New locus for autosomaldominant mitral valve prolapse on chromosome13: clinical insights from genetic studies. Circulation2005; 112: 2022-30.
15. Trochu JN, Kyndt F, Schott JJ, et al. Clinical characteristicsof a familial inherited myxomatous valvulardystrophy mapped to Xq28. J Am Coll Cardiol 2000;35: 1890-7.
16. Segura AM, Luna RE, Horiba K, et al. Immuno histo chemistry of matrix metalloproteinases and their inhibitorsin thoracic aortic aneurysms and aortic valvesof patients with Marfan’s syndrome. Circulation 1998;98: II331-7; discussion II337-8.
17. Read RC, Thal AP, Wendt VE. Symptomatic valvularmyxomatous transformation (the floppy valve syndrome).A possible forme fruste of the Marfan syndrome. Circulation 1965; 32: 897-910.
18. Nasuti JF, Zhang PJ, Feldman MD, et al. Fibrillin andother matrix proteins in mitral valve prolapse syndrome. Ann Thorac Surg 2004; 77: 532-6.
19. Cole WG, Chan D, Hickey AJ, et al. Collagen compositionof normal and myxomatous human mitral heartvalves. Biochem J 1984; 219: 451-60.
20. Rabkin E, Aikawa M, Stone JR, et al. Activatedinterstitial myofibroblasts express catabolic enzymesand mediate matrix remodeling in myxomatous heartvalves. Circulation 2001; 104: 2525-32.
21. Mahimkar R, Nguyen A, Mann M, et al. Cardiac transgenicmatrix metalloproteinase-2 expression inducesmyxomatous valve degeneration: a potential modelof mitral valve prolapse disease. Cardiovasc Pathol 2009; 18: 253-61.
22. Adams DH, Anyanwu AC. Seeking a higher standardfor degenerative mitral valve repair: begin with etiology. J Thorac Cardiovasc Surg 2008; 136: 551-6.
23. Flameng W, Meuris B, Herijgers P, et al. Durability ofmitral valve repair in Barlow disease versus fibroelasticdeficiency. J Thorac Cardiovasc Surg 2008; 135:274-82.
24. Olsen EG, Al-Rufaie HK. The floppy mitral valve. Study on pathogenesis. Br Heart J 1980; 44: 674-83.